CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dugel Pravin −$233K Reporting owner sold <1% of stake
- Saroj Namrata −$232K Chief Business Officer sold 14% of stake
- Heier Jeffrey S. −$112K Chief Scientific Officer sold 4% of stake
- Kaiser Peter −$103K Chief Development Officer sold 5% of stake
- Anderman Todd −$87K Chief Legal Officer sold 8% of stake
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-03 | Goldstein Michael H. President, Ophthalmology & CMO | Grant or award | +63,333 | 313,335 | ||
| 2022-02-03 | Goldstein Michael H. President, Ophthalmology & CMO | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2021-02-17 | Goldstein Michael H. President, Ophthalmology & CMO | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2020-01-30 | Goldstein Michael H. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +215,000 | 215,000 | ||
| 2019-05-28 | Goldstein Michael H. Chief Medical Officer | Purchase | +12,000 | $2.51 | $30K | 25,686 |
| 2019-03-15 | Goldstein Michael H. Chief Medical Officer | Purchase | +10,000 | $4.15 | $42K | 13,686 |
| 2019-01-02 | Goldstein Michael H. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2018-01-31 | Goldstein Michael H. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +83,500 | 83,500 | ||
| 2017-10-02 | Goldstein Michael H. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 |
Page 1 of 1 · 9 trades